XERS XERIS BIOPHARMA HOLDINGS INC
FollowCOM (common), issuer CIK 1867096
Filings received so far for Q3 2026: 9 13F filers report a position in XERS shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Vilga Financial Planning LLC | 1,060,000 | $10.1M | 6.04% | new | 13F-HRTimeline |
| Apella Capital, LLC | 206,004 | $2.08M | 0.03% | -9,893 | 13F-HRTimeline |
| WEALTH ENHANCEMENT ADVISORY SERVICES, L… | 50,547 | $515K | <0.01% | +3,319 | 13F-HRTimeline |
| GK Wealth Management LLC | 3,310 | $31.6K | 0.02% | new | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 2,973 | $28.4K | <0.01% | +316 | 13F-HRTimeline |
| True Wealth Design, LLC | 1,128 | $10.8K | <0.01% | +9 | 13F-HRTimeline |
| MassMutual Private Wealth & Trust, FSB | 814 | $7.78K | <0.01% | -74 | 13F-HRTimeline |
| Versant Capital Management, Inc | 306 | $2.92K | <0.01% | +99 | 13F-HRTimeline |
| GAMMA Investing LLC | 209 | $2K | <0.01% | +99 | 13F-HRTimeline |